Modulation of Endothelial Inflammatory Signature by an Imidazo-Pyrazolyl Urea Derivative in a Dynamic In Vitro Model of Hypertension

Matteo Lusardi, Caterina Bodio, Chiara Brullo, Gianfranco Parati, Pier Luigi Meroni, Maria Orietta Borghi, Elena Raschi, Laura Calvillo · 2026

Read Modulation of Endothelial Inflammatory Signature by an Imidazo-Pyrazolyl Urea Derivative in a Dynamic In Vitro Model of Hypertension by Matteo Lusardi, Caterina Bodio, Chiara Brullo, Gianfranco Parati, Pier Luigi Meroni, Maria Orietta Borghi, Elena Raschi, Laura Calvillo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13416312.txt.

Description

Matteo Lusardi and co-authors test an anti-inflammatory compound in a flowing, pressurized model of hypertension, in 2026. Their bioreactor grows vessel lining cells under pump driven circulation and pressure pulses, separating chemical from mechanical stress. The test compound, an imidazo-pyrazolyl urea called 3l, is known to inhibit cell chemotaxis.

Angiotensin II, a vessel tightening hormone, switched on the inflammatory master switch NF-kappaB in the cells. Compound 3l cut that activation significantly under static, flowing, and pressurized conditions alike. Release of the messenger IL-8 also fell in static and flowing setups. Splitting stress types clarifies where drugs act, the authors note.

Catalog record

CREATORMatteo Lusardi, Caterina Bodio, Chiara Brullo, Gianfranco Parati, Pier Luigi Meroni, Maria Orietta Borghi, Elena Raschi, Laura Calvillo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36878
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13416312

Browse the full library · About the Tower of Babel